NDC 80425-0171-01 - Methocarbamol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0171
- Requested NDC
- 80425-0171-01
- Package NDCs from labels
- 80425-0171-3, 80425-0171-2, 80425-0171-1, 80425-0171-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methocarbamol - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0171-1 | Methocarbamol | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 8 | |
| 80425-0171-2 | Methocarbamol | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 8 | |
| 80425-0171-3 | Methocarbamol | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0171 | METHOCARBAMOL TABLET, FILM COATED [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 8 | Current NDC, Legacy NDC, 3 package rows | 20250101_c9600cc9-7e27-6e19-e053-2995a90ab024.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0171-1 | EA - Each | 80425-0171 | cdc53f27-e0d3-4ffb-8af5-d419758d22bc | 1 | 2023-06-06 |
| 80425-0171-2 | EA - Each | 80425-0171 | 04ca45d9-2d21-4e99-8b9a-247d01ab4b7b | 1 | 2023-06-06 |
| 80425-0171-3 | EA - Each | 80425-0171 | afb9cb2e-d86c-48b1-bb44-f5928747d6fe | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 440bf1ba-a704-4c35-bece-0a0987fc0c11 | 2026-02-16 | Warnings, Adverse reactions | ANDA208507 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 12c8da39-3a0e-4303-9655-29dd83507837 | 2026-02-16 | Warnings, Adverse reactions | ANDA208507 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PHOENIX RX LLC | 4abc29e9-a0cc-06cf-e063-6294a90ad874 | 2026-02-13 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Major Pharmaceuticals | 2df34fa7-9cdc-4be4-ac6f-577122462606 | 2026-02-10 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bostal LLC | d8f10211-f96e-4cf3-9b49-986eb51b703d | 2026-02-04 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | NuCare Pharmaceuticals,Inc. | 72f36d28-15d2-30f6-e053-2a91aa0ad1ce | 2026-01-30 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | UNICHEM PHARMACEUTICALS (USA), INC. | 5777cbb0-b5fd-4b36-ac1d-bc105fe96888 | 2026-01-19 | Warnings, Adverse reactions | ANDA208507 76385-124 197944 197943 1739d3e9-4645-4a0e-bec4-727f8ec63c23 5777cbb0-b5fd-4b36-ac1d-bc105fe96888 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Northwind Health Company, LLC | f2b4ed95-0469-393a-e053-2a95a90a98ed | 2026-01-19 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | NuCare Pharmaceuticals,Inc. | 36c2c31c-8648-7723-e063-6294a90aec98 | 2026-01-14 | Warnings, Adverse reactions | 197944 125OD7737X |
| METHOCARBAMOL | METHOCARBAMOL | DIRECT RX | 31508051-c9cb-149b-e054-00144ff88e88 | 2026-01-08 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | AvPAK | be37bc85-6a41-00d8-e053-2a95a90ae504 | 2026-01-08 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Northwind Health Company, LLC | f2b4ed5f-3489-9ee4-e053-2995a90a25f0 | 2026-01-01 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Northwind Health Company, LLC | f31ccb09-7a9a-60af-e053-2995a90a6e97 | 2026-01-01 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Northwind Health Company, LLC | df63611f-90e4-6bbe-e053-2a95a90a2aad | 2026-01-01 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Proficient Rx LP | e4ebe9cf-a274-47c7-b740-4b3d6e9dc52b | 2026-01-01 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Redpharm Drug | 46e983de-434e-7ff3-e063-6394a90aa466 | 2025-12-27 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Aphena Pharma Solutions - Tennessee, LLC | 18810520-3040-4802-e063-6294a90a1ec0 | 2025-12-03 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Asclemed USA, Inc. | 7f297ac6-a580-4539-a770-fe5d15c2b922 | 2025-11-24 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | Marlex Pharmaceuticals, Inc. | d2e38ac9-1cf3-14ca-e053-2a95a90a8522 | 2025-11-21 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Oncora Pharma, LLC | 440d6c99-8aca-af07-e063-6294a90aee3d | 2025-11-20 | Warnings, Adverse reactions | 125OD7737X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.